105 related articles for article (PubMed ID: 28042324)
1. Mapping Sentinel Lymph Node Metastasis by Dual-probe Optical Imaging.
Yang X; Wang Z; Zhang F; Zhu G; Song J; Teng GJ; Niu G; Chen X
Theranostics; 2017; 7(1):153-163. PubMed ID: 28042324
[No Abstract] [Full Text] [Related]
2. Development of Sentinel LN Imaging with a Combination of HAase Based on a Comprehensive Analysis of the Intra-lymphatic Kinetics of LPs.
Gomi M; Sakurai Y; Okada T; Miura N; Tanaka H; Akita H
Mol Ther; 2021 Jan; 29(1):225-235. PubMed ID: 32966771
[TBL] [Abstract][Full Text] [Related]
3. Performance of Molecular Lymphosonography for Detection and Quantification of Metastatic Involvement in Sentinel Lymph Nodes.
Nam K; Stapp R; Liu JB; Stanczak M; Forsberg F; O'Kane PL; Lin Z; Zhu Z; Li J; Solomides CC; Eisenbrey JR; Lyshchik A
J Ultrasound Med; 2019 Aug; 38(8):2103-2110. PubMed ID: 30589454
[TBL] [Abstract][Full Text] [Related]
4. Use of panitumumab-IRDye800 to image microscopic head and neck cancer in an orthotopic surgical model.
Heath CH; Deep NL; Sweeny L; Zinn KR; Rosenthal EL
Ann Surg Oncol; 2012 Nov; 19(12):3879-87. PubMed ID: 22669455
[TBL] [Abstract][Full Text] [Related]
5. NIR-II Ratiometric Fluorescence Probes Enable Precise Determination of the Metastatic Status of Sentinel Lymph Nodes.
Li M; Sun B; Zheng X; Ma S; Zhu S; Zhang S; Wang X
ACS Sens; 2024 Mar; 9(3):1339-1348. PubMed ID: 38382082
[TBL] [Abstract][Full Text] [Related]
6. New and effective EGFR-targeted fluorescence imaging technology for intraoperative rapid determination of lung cancer in freshly isolated tissue.
Li C; Mi J; Wang Y; Zhang Z; Guo X; Zhou J; Hu Z; Tian J
Eur J Nucl Med Mol Imaging; 2023 Jan; 50(2):494-507. PubMed ID: 36207638
[TBL] [Abstract][Full Text] [Related]
7. A novel near-infrared EGFR targeting probe for metastatic lymph node imaging in preclinical mouse models.
Xie D; Li Y; Shi J; Zhu YP; Wang Y; Butch CJ; Wang Z
J Nanobiotechnology; 2023 Sep; 21(1):342. PubMed ID: 37736720
[TBL] [Abstract][Full Text] [Related]
8. In vivo molecular imaging to diagnose and subtype tumors through receptor-targeted optically labeled monoclonal antibodies.
Koyama Y; Barrett T; Hama Y; Ravizzini G; Choyke PL; Kobayashi H
Neoplasia; 2007 Dec; 9(12):1021-9. PubMed ID: 18084609
[TBL] [Abstract][Full Text] [Related]
9. Intraoperative diagnosis of early lymphatic metastasis using neodymium-based rare-earth NIR-II fluorescence nanoprobe.
Duan G; Zhang J; Wei Z; Wang X; Zeng J; Wu S; Hu C; Wen L
Nanoscale Adv; 2023 Aug; 5(16):4240-4249. PubMed ID: 37560436
[TBL] [Abstract][Full Text] [Related]
10. Docetaxel administered through a novel lymphatic drug delivery system (LDDS) improved treatment outcomes for lymph node metastasis.
Sukhbaatar A; Mori S; Sugiura T; Kodama T
Biomed Pharmacother; 2024 Feb; 171():116085. PubMed ID: 38171241
[TBL] [Abstract][Full Text] [Related]
11. Active Targeting Hyaluronan Conjugated Nanoprobe for Magnetic Particle Imaging and Near-Infrared Fluorescence Imaging of Breast Cancer and Lung Metastasis.
Yang CW; Liu K; Yao CY; Li B; Juhong A; Ullah AKMA; Bumpers H; Qiu Z; Huang X
ACS Appl Mater Interfaces; 2024 May; ():. PubMed ID: 38757711
[TBL] [Abstract][Full Text] [Related]
12. Deep Learning and Registration-Based Mapping for Analyzing the Distribution of Nodal Metastases in Head and Neck Cancer Cohorts: Informing Optimal Radiotherapy Target Volume Design.
Weissmann T; Mansoorian S; May MS; Lettmaier S; Höfler D; Deloch L; Speer S; Balk M; Frey B; Gaipl US; Bert C; Distel LV; Walter F; Belka C; Semrau S; Iro H; Fietkau R; Huang Y; Putz F
Cancers (Basel); 2023 Sep; 15(18):. PubMed ID: 37760588
[TBL] [Abstract][Full Text] [Related]
13. Virtual Staining of Nonfixed Tissue Histology.
Pillar N; Li Y; Zhang Y; Ozcan A
Mod Pathol; 2024 May; 37(5):100444. PubMed ID: 38325706
[TBL] [Abstract][Full Text] [Related]
14. Improved Tumor Uptake by Optimizing Liposome Based RES Blockade Strategy.
Sun X; Yan X; Jacobson O; Sun W; Wang Z; Tong X; Xia Y; Ling D; Chen X
Theranostics; 2017; 7(2):319-328. PubMed ID: 28042337
[TBL] [Abstract][Full Text] [Related]
15. Tri-stimuli-responsive biodegradable theranostics for mild hyperthermia enhanced chemotherapy.
Lu N; Huang P; Fan W; Wang Z; Liu Y; Wang S; Zhang G; Hu J; Liu W; Niu G; Leapman RD; Lu G; Chen X
Biomaterials; 2017 May; 126():39-48. PubMed ID: 28254692
[TBL] [Abstract][Full Text] [Related]
16. Toxic Reactive Oxygen Species Enhanced Synergistic Combination Therapy by Self-Assembled Metal-Phenolic Network Nanoparticles.
Dai Y; Yang Z; Cheng S; Wang Z; Zhang R; Zhu G; Wang Z; Yung BC; Tian R; Jacobson O; Xu C; Ni Q; Song J; Sun X; Niu G; Chen X
Adv Mater; 2018 Feb; 30(8):. PubMed ID: 29315862
[TBL] [Abstract][Full Text] [Related]
17. Combination Treatment of Patients with BRAF-Mutant Melanoma: A New Standard of Care.
Simeone E; Grimaldi AM; Festino L; Vanella V; Palla M; Ascierto PA
BioDrugs; 2017 Feb; 31(1):51-61. PubMed ID: 28058658
[TBL] [Abstract][Full Text] [Related]
18. An Experimental Analysis of the Molecular Effects of Trastuzumab (Herceptin) and Fulvestrant (Falsodex), as Single Agents or in Combination, on Human HR+/HER2+ Breast Cancer Cell Lines and Mouse Tumor Xenografts.
Chen Q; Weng Z; Lu Y; Jia Y; Ding L; Bai F; Ge M; Lin Q; Wu K
PLoS One; 2017; 12(1):e0168960. PubMed ID: 28045951
[TBL] [Abstract][Full Text] [Related]
19. Ratiometric Photoacoustic Molecular Imaging for Methylmercury Detection in Living Subjects.
Liu Y; Wang S; Ma Y; Lin J; Wang HY; Gu Y; Chen X; Huang P
Adv Mater; 2017 May; 29(17):. PubMed ID: 28224711
[TBL] [Abstract][Full Text] [Related]
20. TAT-Modified Gold Nanoparticle Carrier with Enhanced Anticancer Activity and Size Effect on Overcoming Multidrug Resistance.
Wang RH; Bai J; Deng J; Fang CJ; Chen X
ACS Appl Mater Interfaces; 2017 Feb; 9(7):5828-5837. PubMed ID: 28124900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
